Objective To investigate the effects of microRNA-338-3p (miR-338-3p) overexpression on proliferation and invasion of prostate cancer cells and to elucidate its mechanism of action. Methods RT-qPCR and Western blot were used to detect the expression levels of miR-338-3p and a disintegrin and metalloproteinase 17 (ADAM17) in human prostate epithelial cells RWPE-1 and prostate cancer cell lines LNCaP, PC-3, and DU145. miR-338-3p was overexpressed in LNCaP cells. LNCaP cells were divided into blank group, transfection empty vector group (NC mimics group), and transfection miR-338-3p analog group (miR-338-3p mimics group). After overexpression of miR-338-3p, cell proliferation and invasion ability were detected by clone formation assay and Transwell invasion assay. Western blot was used to detect the expression of epithelial-mesenchymal transition (EMT)-related proteins (E-Cadherin, N-Cadherin, Vimentin). Bioinformatics methods were employed to predict downstream target genes. Dual-luciferase reporter gene assay and Western blot were conducted to verify the targeting relationship between miR-338-3p and ADAM17. Further divide LNCaP cells into two groups: the miR-338-3p mimic and plasmid empty vector group (miR-338-3p mimics+oe NC group), and the miR-338-3p mimic and ADAM17 overexpression plasmid group (miR-338-3p mimics+oe ADAM17 group). Cell proliferation and invasion ability were detected by clone formation assay and Transwell invasion assay, and Western blot was performed to detect E-Cadherin, N-Cadherin, and Vimentin protein expression. Results Compared with RWPE-1 cells, miR-338-3p expression was significantly downregulated and ADAM17 expression was significantly upregulated in LNCaP, PC-3, and DU145 cells (P<0.05). No statistically significant differences were found in proliferation and invasion ability or in the protein expression levels of E-Cadherin, N-Cadherin, Vimentin, and ADAM17 between the control group and the NC-mimics group (P> 0.05). Compared with the NC-mimics group, the miR-338-3p mimics group showed significantly reduced LNCaP cell proliferation and invasion ability, upregulated E-Cadherin protein expression, and downregulated N-Cadherin, Vimentin, and ADAM17 protein expression (P<0.05). Bioinformatics prediction and dual-luciferase reporter gene assay confirmed that ADAM17 is a downstream target gene of miR-338-3p. Rescue experiments showed that, compared with the miR-338-3p mimics + oe-NC group, the miR-338-3p mimics + oe-ADAM17 group exhibited significantly enhanced cell proliferation and invasion ability (P<0.05), decreased E-Cadherin protein expression, and increased N-Cadherin and Vimentin protein expression (P<0.05). Conclusion miR-338-3p is downregulated in prostate cancer cells. Overexpression of miR-338-3p inhibits the EMT process by targeting and downregulating ADAM17 expression, thereby suppressing the proliferation and invasion of LNCaP cells.